NCT03152747

Brief Summary

Phacoemulsification with implantation of posterior chamber lenses represents the gold standard of care for patients needing lens surgery, but there is an increased risk of developing pseudophakic retinal detachment after surgery. Especially myopic patients have an even higher risk of pseudophakic retinal detachment compared to the general population. The aim of this multicenter study is to document the presence and/or post-operative development of posterior vitreous detachment (PVD) and to assess its influence on the incidence of retinal detachment (RD) in myopes in a time period of three and five years after lens surgery. 618 eyes of patients scheduled for regular lens surgery will be included, defined by an axial length of 25.0 mm or more. To examine the vitreous status, all patients will receive a comprehensive eye examination pre-operatively, including funduscopy with assessment of a Weiss ring and optical coherence tomography (OCT). Patients will be divided into two groups, group A with pre-operative complete PVD and group B with no/partial PVD. Group A will be invited for one follow-up visit (two months post-operatively) followed up by telephone interviews at one, two, three and five years after surgery to determine occurrence of pseudophakic retinal detachment. Group B will be invited for follow-up examinations at two months, six months and one year after surgery to document occurrence of PVD (if a PVD is present at one of the follow-ups, no more visits are necessary). Two, three and five years after surgery, all patients from group B will be interviewed by telephone, as in group A, to document the occurrence of pseudophakic retinal detachment. In the recent literature the association between the occurrence of PVD pre-/post-operative and RD after lens surgery is well documented but not described for myopic patients. The results of this multicenter study should help to tackle the problem of RD prediction in myopic patients depending on their pre-operative vitreous status, especially in the setting of refractive lens exchange.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
609

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 19, 2017

Completed
8 days until next milestone

Study Start

First participant enrolled

April 27, 2017

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 15, 2017

Completed
7.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2024

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 14, 2025

Completed
Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

7.5 years

First QC Date

April 19, 2017

Last Update Submit

March 10, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • PVD status

    Number of patients with preoperative and/or post-operatively developed posterior vitreous detachment (PVD)

    1 year

  • Incidence of RD

    Influence of PVD on the incidence of retinal detachment (RD) in myopes after lens surgery.

    5 years

Interventions

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study population: target 618. The participants will be selected by the clinical investigators at several ophthalmological centres in Austria, Belgium, Spain, Norway and the Netherlands. As the study population is already scheduled for cataract surgery / refractive lens exchange, recruitment will be performed directly in these centres at the pre-assessment visits. At this visit, optical biometry is performed and patients with suitable axial eye lengths will be screened. If all inclusion and no exclusion criteria are met the patients will be asked to participate in the trial.

You may qualify if:

  • Minimum 21 years of age
  • Patients scheduled for lens surgery with an axial eye length of 25.0 mm or more
  • Availability, willingness, sufficient cognitive awareness to comply with examination procedures
  • Ability to sign informed consent

You may not qualify if:

  • Patients with combined surgery (e.g. combined phacoemulsification and vitrectomy or trabeculectomy or DSAEK)
  • Patients with previous intraocular surgery (except any kind of laser surgery e.g. retinopexy, refractive laser surgery)
  • Patients with recurrent severe anterior or posterior segment inflammation or uveitis of unknown aetiology, or any disease producing an inflammatory reaction in the eye
  • Any ophthalmological pathology with the potential to compromise the measurements (e.g. mature/very dense cataract, fixation difficulties)
  • Penetrating ocular trauma
  • Previous history of retinal detachment
  • Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with the fluctuation of hormones that could lead to refractive changes
  • Patients participating in another study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vienna Institute for Research in Ocular Surgery

Vienna, Vienna, 1140, Austria

Location

MeSH Terms

Conditions

MyopiaCataract

Condition Hierarchy (Ancestors)

Refractive ErrorsEye DiseasesLens Diseases

Study Officials

  • Oliver Findl, Prof. Dr.

    Vienna Institute for Research in Ocular Surgery

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principle Investigator, Sponsor

Study Record Dates

First Submitted

April 19, 2017

First Posted

May 15, 2017

Study Start

April 27, 2017

Primary Completion

October 30, 2024

Study Completion

September 14, 2025

Last Updated

March 13, 2026

Record last verified: 2026-03

Locations